COURSE OF SPECIFIC T-LYMPHOCYTE CYTOTOXICITY, PLASMA AND CELLULAR VIRAL LOADS, AND NEUTRALIZING ANTIBODY-TITERS IN 17 RECENTLY SEROCONVERTED HIV TYPE 1-INFECTED PATIENTS
E. Legrand et al., COURSE OF SPECIFIC T-LYMPHOCYTE CYTOTOXICITY, PLASMA AND CELLULAR VIRAL LOADS, AND NEUTRALIZING ANTIBODY-TITERS IN 17 RECENTLY SEROCONVERTED HIV TYPE 1-INFECTED PATIENTS, AIDS research and human retroviruses, 13(16), 1997, pp. 1383-1394
Relationships were sought between specific anti-HIV cytotoxic T lympho
cyte (CTL) responses (against structural and regulatory proteins of th
e HIV-1 LAI isolate) and plasma and cellular viral loads (VLs) in 17 r
ecently HIV-1-infected patients including 3 displaying asymptomatic pr
imary infection (PI) followed up for 12 months, Plasma VL was correlat
ed directly with CD8 counts and inversely with CD4 counts, Cytotoxic r
eactions were observed in all patients and directed mainly against str
uctural proteins, The earliest CTL responses were against Gag and Env
proteins detected in 87 and 75% of the subjects, respectively, within
the first month following PI, Anti-Env and Gag cytotoxic responses wer
e inversely correlated with the plasma VL, Reactions against the pol g
ene products were thought to be either less involved in or less effici
ent for the initial decrease of viremia, Responses against regulatory
gene products were weak and variable, apart from Nef, which was recogn
ized by half of the subjects, Neutralizing antibodies were not detecte
d before month 3, and were found only in six patients at subsequent ti
mes, Two of three patients with asymptomatic PI had a low viral burden
and either a delayed response or one limited to a few protein CTL res
ponses, suggesting that the magnitude of the CTL response depends on t
he initial plasma VL, The third patient displayed viral and CTL parame
ters identical to those of the patients with symptomatic PI. However,
two subjects with symptomatic PI exhibited similarly low plasma VL and
moderate CTL responses, Overall, the results suggest that the CTL res
ponse may not be the sole factor controlling viremia.